BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25907632)

  • 1. The KM-parkin-DB: A Sub-set MutationView Database Specialized for PARK2 (PARKIN) Variants.
    Mitsuyama S; Ohtsubo M; Minoshima S; Shimizu N
    Hum Mutat; 2015 Aug; 36(8):E2430-40. PubMed ID: 25907632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of autosomal recessive juvenile Parkinson's disease mutations on the structure and interactions of the parkin ubiquitin-like domain.
    Safadi SS; Barber KR; Shaw GS
    Biochemistry; 2011 Apr; 50(13):2603-10. PubMed ID: 21348451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism (PARK2).
    Nakaso K; Adachi Y; Yasui K; Sakuma K; Nakashima K
    Neurosci Lett; 2006 May; 400(1-2):44-7. PubMed ID: 16517073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
    Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
    J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein.
    Biswas R; Bagchi A
    Gene; 2017 Apr; 610():49-58. PubMed ID: 28189762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism.
    Illarioshkin SN; Periquet M; Rawal N; Lücking CB; Zagorovskaya TB; Slominsky PA; Miloserdova OV; Markova ED; Limborska SA; Ivanova-Smolenskaya IA; Brice A
    Mov Disord; 2003 Aug; 18(8):914-9. PubMed ID: 12889082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of phospho-ubiquitin-induced PARKIN activation.
    Wauer T; Simicek M; Schubert A; Komander D
    Nature; 2015 Aug; 524(7565):370-4. PubMed ID: 26161729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.
    Fiesel FC; Caulfield TR; Moussaud-Lamodière EL; Ogaki K; Dourado DF; Flores SC; Ross OA; Springer W
    Hum Mutat; 2015 Aug; 36(8):774-86. PubMed ID: 25939424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism.
    Shimizu N; Asakawa S; Minoshima S; Kitada T; Hattori N; Matsumine H; Yokochi M; Yamamura Y; Mizuno Y
    J Neural Transm Suppl; 2000; (58):19-30. PubMed ID: 11128608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational Impact on "in-Between-Ring" (IBR) Domain of PARKIN on Protein Stability and Function.
    Biswas S; Bagchi A
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1603-1616. PubMed ID: 33471285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism.
    Lesage S; Magali P; Lohmann E; Lacomblez L; Teive H; Janin S; Cousin PY; Dürr A; Brice A;
    Hum Mutat; 2007 Jan; 28(1):27-32. PubMed ID: 17068781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India.
    Vinish M; Prabhakar S; Khullar M; Verma I; Anand A
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):166-70. PubMed ID: 19734163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3eta is a novel regulator of parkin ubiquitin ligase.
    Sato S; Chiba T; Sakata E; Kato K; Mizuno Y; Hattori N; Tanaka K
    EMBO J; 2006 Jan; 25(1):211-21. PubMed ID: 16096643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of the Parkin gene in a Persian family: clinical progression over a 40-year period.
    Clarimon J; Johnson J; Djaldetti R; Hernandez D; Hattori N; Sroka H; Barhom Y; Singleton A
    Mov Disord; 2005 Jul; 20(7):887-90. PubMed ID: 15852366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine Parkin: molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant.
    Bjerre D; Madsen LB; Bendixen C; Larsen K
    Biochem Biophys Res Commun; 2006 Sep; 347(3):803-13. PubMed ID: 16844087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
    Beasley SA; Hristova VA; Shaw GS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.